🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Samuel W. Brady

St. Jude Children's Research Hospital

ORCID: 0000-0001-5518-7800
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy

(2023)10.1158/2643-3230.c.6550230.v1
Top 100%
0DataRank
Top 100%0 citations

John Choi, Kathryn G. Roberts, Deqing Pei, Elaine Coustan‐Smith, Hiroto Inaba +17 more

Papers

Driven by 19 papers — median percentile 0. Top paper: “Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor”.

Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor

Cell Genomics(2022)10.1016/j.xgen.2022.100179
N/A
4.8DataRank · unranked
366 citations

Marcos Díaz‐Gay, Yang Wu, Mark Barnes, Raviteja Vangara, Erik N. Bergstrom +30 more

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations

Nature Communications(2020)10.1038/s41467-020-18987-4
N/A
3.7DataRank · unranked
175 citations

Yanling Liu, Xiaotu Ma, Alexander M. Gout, Kohei Hagiwara, Xin Zhou +19 more

Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0229
N/A
0.764DataRank · unranked
162 citations

John Choi, Kathryn G. Roberts, Deqing Pei, Elaine Coustan‐Smith, Hiroto Inaba +17 more

The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms

Nature Communications(2021)10.1038/s41467-021-21255-8
N/A
0.639DataRank · unranked
70 citations

Jing Ma, Jennifer L. Kamens, Tamara Westover, Michael P. Walsh, Samuel W. Brady +23 more

Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia

Blood(2022)10.1182/blood.2022015444
N/A
0.596DataRank · unranked
52 citations

Lindsey E. Montefiori, Ilaria Iacobucci, Yaqi Zhao, Qingsong Gao, Elisabeth Paietta +31 more

Exploration of Coding and Non-coding Variants in Cancer Using GenomePaint

Cancer Cell(2021)10.1016/j.ccell.2020.12.011
N/A
0.550DataRank · unranked
38 citations

Jian Wang, Jaimin Patel, Marc Valentine, Ying Shao, Scott Newman +15 more

Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia

Nature Communications(2025)10.1038/s41467-025-56229-7
N/A
0.416DataRank · unranked
15 citations

Huanbin Zhao, Wenjian Yang, Maud Maillard, Satoshi Yoshimura, Yu-Chih Hsiao +22 more

The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.25.432934
N/A
0.292DataRank · unranked
6 citations

William C. Wright, Rich Chapple, Asif Zubair, Manbir Sandhu, Jake E. Batchelder +24 more

Somatic mitochondrial DNA mutations are a source of heterogeneity among primary leukemic cells

medRxiv(2024)10.1101/2024.09.26.24314381
N/A
0.165DataRank · unranked
2 citations

Catherine E. Welsh, Yonghui Ni, Liang Ding, Melissa Franco, Robert J. Autry +22 more

Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies

Genome Medicine(2021)10.1186/s13073-021-00989-6
N/A
0DataRank · unranked
12 citations

義行 高橋, Samuel W. Brady, Rachel E. Factor, Erinn Downs‐Kelly, Andrew Farrell +8 more

Novel temporal and spatial patterns of metastatic colonization from rapid-autopsy tumor biopsies

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.03.446803
N/A
0DataRank · unranked
0 citations

義行 高橋, Samuel W. Brady, Rachel E. Factor, Erinn Downs‐Kelly, Andrew Farrell +8 more

Combating subclonal evolution of resistant cancer phenotypes

UNC Libraries(2020)10.17615/hett-8q86
N/A
0DataRank · unranked
0 citations

Aaron R. Quinlan, Rachel E. Factor, Ryan M. Layer, Layla A. Anderson, David F. Jenkins +23 more

A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.12.989251
N/A
0DataRank · unranked
1 citations

Jiayi Liu, Samuel W. Brady, Patrick A. Cosgrove, Aritro Nath, Jasmine A. McQuerry +6 more

Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL

Blood Advances(2023)10.1182/bloodadvances.2021006881
N/A
0DataRank · unranked
3 citations

Karensa Tjoa, Benjamin J. Huang, Lauren K. Meyer, Mi‐Ok Kim, Samuel W. Brady +4 more

Data from Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy

(2023)10.1158/2643-3230.c.6550230.v1
Top 100%
0DataRank
Top 100%0 citations

John Choi, Kathryn G. Roberts, Deqing Pei, Elaine Coustan‐Smith, Hiroto Inaba +17 more

Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia

Research Square(2024)10.21203/rs.3.rs-5292018/v1
N/A
0DataRank · unranked
3 citations

Emily Ashcraft, Ti‐Cheng Chang, Kathryn G. Roberts, Samuel W. Brady, Yiping Fan +22 more

The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

Nature Communications(2021)10.1038/s41467-021-26640-x
N/A
0DataRank · unranked
93 citations

William C. Wright, Richard H. Chapple, Asif Zubair, Manbir Sandhu, Jake E. Batchelder +25 more

A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

Translational Oncology(2020)10.1016/j.tranon.2020.100946
N/A
0DataRank · unranked
17 citations

Jiayi Liu, Samuel W. Brady, Patrick A. Cosgrove, Aritro Nath, Jasmine A. McQuerry +6 more

The landscape of coding RNA editing events in pediatric cancer

BMC Cancer(2021)10.1186/s12885-021-08956-5
N/A
0DataRank · unranked
24 citations

Michael Rusch, Samuel W. Brady, Ying Shao, Michael N. Edmonson, Timothy I. Shaw +8 more